v3.25.2
Earnings (Loss) Per Share (Tables)
9 Months Ended
Jun. 30, 2025
Earnings Per Share [Abstract]  
Computation of Basic and Diluted Earnings per Share

The following is the computation of basic and diluted earnings (loss) per share ("EPS") from continuing operations attributable to Ashland. Stock appreciation rights and warrants available to purchase shares outstanding for each reporting period whose exercise price was greater than the average market price of Ashland common stock for each applicable period were not included in the computation of income (loss) from continuing operations per diluted share because the effect of these instruments would be antidilutive. The total number of these shares outstanding was approximately 2 million and 1 million at June 30, 2025 and 2024, respectively. The majority of these shares are for warrants with a strike price of $128.66. EPS is reported under the treasury stock method.

 

 

Three months ended

 

 

Nine months ended

 

 

 

June 30

 

 

June 30

 

(In millions, except per share data)

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Numerator

 

 

 

 

 

 

 

 

Numerator for basic and diluted EPS - Income (loss) from continuing operations, net of tax

 

$

(719

)

 

$

31

 

 

$

(855

)

 

$

180

 

Denominator

 

 

 

 

 

 

 

 

Denominator for basic EPS - Weighted-average common shares outstanding

 

 

46

 

 

 

50

 

 

 

47

 

 

 

50

 

Share based awards convertible to common shares

 

 

 

 

 

1

 

 

 

 

 

 

1

 

Denominator for diluted EPS - Adjusted weighted-average shares and assumed conversions

 

 

46

 

 

 

51

 

 

 

47

 

 

 

51

 

EPS from continuing operations

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

(15.70

)

 

$

0.61

 

 

$

(18.39

)

 

$

3.57

 

Diluted(a)

 

 

(15.70

)

 

 

0.60

 

 

 

(18.39

)

 

 

3.53

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(a)
As a result of the loss from continuing operations attributable to Ashland during the three and nine months ended June 30, 2025, the effect of the share-based awards convertible to common stock would be antidilutive and have been excluded from the diluted EPS calculation.